FDA Approves Weight Loss Drug Contrave

FDA Approves Weight Loss Drug Contrave. See this week’s Item #4.

FDA Advisory Panel Recommends Approval of Novo Nordisk’s liraglutide (used now as Victoza to treat type 2 diabetes ) for use in chronically obese patients with at least one weight-related health issue. More news to come. The new drug would be called Saxenda.